Avalon Globocare Corp is a commercial-stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services..
Avalon GloboCare News
Avalon Provides Update on POOL/PACT InitiativeFREEHOLD, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASD...
Company Continues to Execute Growth Strategy Focused on Next-Generation Agentic AI SystemsFREEHOLD, N.J., June 04, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Cor...
AWS collaboration accelerates Catch-Up Phase 2 development to a fully autonomous Agentic AI Video PlatformFREEHOLD, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Ava...
Collaboration Strengthens Development Roadmap and Supports Scalable Growth and MonetizationFREEHOLD, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare C...
$3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of WarrantsFREEHOLD, N.J., Feb. 27, 2026 (...
Avalon GloboCare (ALBT) announced that it has been accepted into the Advanced Micro Devices (AMD) AI Developer Program, providing the Company with access to AMD...
$3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of WarrantsFREEHOLD, N.J., Feb. 26, 2026 (...
Avalon GloboCare stock skyrocketed today as its subsidiary secured a spot in AMD's AI Developer Program. Here’s why ALBT shares remain super risky to own stil...
Elong Power Holding Ltd. 56,351,790 0.1533...
Disclaimer: